Zubayr Hamza of South Africa tested positive for a banned drug during an anti-doping
test performed by the International Cricket Council (ICC) on March 17, 2022.
The substance was identified as Furosemide, and a diuretic used to treat hypertension and reduce swelling caused by fluid build-up in the body. It is not a performance-enhancing substance.
Meanwhile, Hamza has agreed to cooperate with the ICC and has voluntarily suspended his activities. According to the CSA statement, the authorities – CSA, SACA, and WPCA – are "helping him in the process," according to the CSA statement.
Zubayr Hamza, a Proteas player, has tested positive for a prohibited substance under the International Cricket Council (ICC) anti-doping code, according to Cricket South Africa (CSA), the South African Cricketers' Association (SACA), and the Western Province Cricket Association (WPCA). On January 17 2022, an ICC anti-doping test yielded a positive result.
Zubayr does not contest the positive test, fully cooperates with the ICC, and has agreed to a voluntary suspension immediately. At the same time, formal submissions to the ICC are prepared.
The positive test was for the drug Furosemide, which isn't a performance enhancer, and Zubayr could figure out how the substance got into his system. The next step will be to prove that Zubayr was not at fault or negligent or that there was no severe fault or carelessness on his behalf.
Zubayr is being supported by the CSA, SACA, and WPCA in this process, and they will continue to do so until the problem is resolved.
The right-hander, who made his Test debut against Pakistan in 2019, has only struck one half-century in 12 innings for his country. In 2021, he made his One Day International debut against the Netherlands, scoring a half-century in the first match before the three-match series was called off owing to the threat of the Covid-19 Omicron version. Due to personal circumstances, the 26-year-old resigned from the ongoing series against Bangladesh.
The substance was identified as Furosemide, and a diuretic used to treat hypertension and reduce swelling caused by fluid build-up in the body. It is not a performance-enhancing substance.
Meanwhile, Hamza has agreed to cooperate with the ICC and has voluntarily suspended his activities. According to the CSA statement, the authorities – CSA, SACA, and WPCA – are "helping him in the process," according to the CSA statement.
Zubayr Hamza, a Proteas player, has tested positive for a prohibited substance under the International Cricket Council (ICC) anti-doping code, according to Cricket South Africa (CSA), the South African Cricketers' Association (SACA), and the Western Province Cricket Association (WPCA). On January 17 2022, an ICC anti-doping test yielded a positive result.
Zubayr does not contest the positive test, fully cooperates with the ICC, and has agreed to a voluntary suspension immediately. At the same time, formal submissions to the ICC are prepared.
The positive test was for the drug Furosemide, which isn't a performance enhancer, and Zubayr could figure out how the substance got into his system. The next step will be to prove that Zubayr was not at fault or negligent or that there was no severe fault or carelessness on his behalf.
Zubayr is being supported by the CSA, SACA, and WPCA in this process, and they will continue to do so until the problem is resolved.
The right-hander, who made his Test debut against Pakistan in 2019, has only struck one half-century in 12 innings for his country. In 2021, he made his One Day International debut against the Netherlands, scoring a half-century in the first match before the three-match series was called off owing to the threat of the Covid-19 Omicron version. Due to personal circumstances, the 26-year-old resigned from the ongoing series against Bangladesh.